BB
Bone Biologics Corporation
BBLGW · NASDAQ
$7.62 +58.75% (+$2.82)
1M +37.50%
Market Cap $13.7M
P/E Ratio -
Div. Yield -
ROE 57.85%
Bulios Fair Price
$5.64
26.0% downside
Current Price
$7.62
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BBLGW is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
1/9Valuation
59 /100
Fair P/B 3.49x
EV/EBITDA N/A
P/S N/A
Growth
8 /100
Declining Book val. growth 3.30%
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor ROE 57.85%
ROA 65.16%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 8.67x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
48 /100
Moderate EPS volatility 47.56%
Profitable years 0
Beta 0.53x
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BBLGW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jeffrey Frelick
Employees
2
Headquarters
Burlington
Upcoming events
02 DEC
Earnings
Upcoming earnings report